• June 340B Insider

    Welcome to the June edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   340B UPDATES   21st Century Cures Act Moves Forward Without 340B Language On May 21, the House Energy and Commerce Committee unanimously approved the 21st Century Cures Act (H.R. 6) without the inclusion of… Read more »

  • March 340B Insider

      Welcome to the March edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   UPDATE FROM 340B COALITION WINTER CONFERENCE   RxStrategies’ Increased Presence at 340B Coalition Winter Conference RxStrategies continues to work closely with SNHPA, as one of two Pinnacle Leader Corporate Partners, supporting educational… Read more »

  • December 340B Insider

    340B Winter Coalition Conference Mark your calendars for the 11th Annual 340B Coalition Winter Conference, from Feb. 4 to 6, 2015 at the Hyatt Regency Embarcadero in San Francisco. RxStrategies invites you to schedule a meeting time or stop by our booth #18-19 in the exhibit hall. Our team will greet you and answer any… Read more »

  • HRSA published final rule on Orphan Drugs

    On July 23, 2013, the Health Resources and Services Administration (HRSA) published a final rule to clarify how section 340B(e) of the Public Health Service Act (PHSA) will be implemented (“Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program”, (78 Fed. Reg. 44016 (July 23, 2013)). The final rule only applies to Critical… Read more »